Radiofrequency and cryotherapy taking greater share of ablation market

Radiofrequency ablation and cryotherapy/cryosurgery will gain the greatest increase in share of the total ablation technologies market worldwide through 2019, with growth coming directly at the expense of all other modalities, according to the 2010 report by MedMarket Diligence, “Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities.”

Source: Data drawn from Report #A145, “Ablation Technologies Worldwide.”

Technologies employed in ablation, in addition to RF and cryo,  include electrical, light/laser, ultrasound, thermal, microwave, hydromechanical, radiation and thermal. The modalities demonstrate varying effects on tissues, with greater or lesser capacity to effectively ablation target tissues while minimizing cell death or damage in adjacent tissues. The technologies also vary by the associated capital equipment and, if any, disposable costs.

The net result is that radiofrequency and cryotherapy will gain greater hold of the aggregate market.  To be clear, though, all segments of the ablation market are growing, from a low of about 3% annually for thermal technologies to a high of almost 20% annually for cryotherapy.

.

2 thoughts on “Radiofrequency and cryotherapy taking greater share of ablation market”

  1. According to the latest studies coming out from multiple sources at the Universities in Europe, it looks like MicroWave methodology will get te greatest growth in the market in teh next 10 years. Could you pleas justify the completely different datas shows in the diagram?

    Thanks

  2. It’s a bit hard to respond to “multiple sources” without knowing what they are, what they are measuring and what their methodologies are, among other things. However, the data we display is based on reported manufacturer revenues and the anticipated change in the aggregate share of the global med/surg ablation market over the 2009-2019 time period. Here, radiofrequency has demonstrated and will demonstrate the biggest increase in market share. This in part ensues from the larger established market volume for radiofrequency ablation (we show almost $1.6 billion in 2010), while microwave currently only represents a $194 million global market. Nonetheless, even considering the compound annual growth rate (giving favor to the smaller market of microwave), the greatest growth rate is coming first from cryotherapy (smaller based revenues than RF so the aggregate share change is less than for RF) and secondarily from radiofrequency. Please note that these are reported manufacturer revenues and increases from year-over-year reported revenues historically and predictable increases based on past trend, emerging product approvals, trends in clinical applications and rates of adoption.

Leave a Reply